Contacts, documents and full notice history are available with a subscription.

Award Notice NONE 1 notice 1 document

Lenalidomide Generic Med 36C25726N0241

Solicitation 36C25726N0241 Copied Notice ID 28b8c97608964142bb70fe6da1ef8815 Copied VETERANS AFFAIRS, DEPARTMENT OF — 257-NETWORK CONTRACT OFFICE 17 (36C257)

SAM.gov

Posted

Feb 05, 2026

Deadline

No deadline

Set-aside

NONE

NAICS

325412

PSC

6505

Summary

AI-generated · Feb 06, 2026

Provide a reliable, continuous supply of generic lenalidomide, an oral immunomodulatory medication used to treat multiple myeloma, anemia in myelodysplastic syndromes, and certain types of lymphoma.

Awarded to Exelan Pharmaceuticals Inc for approximately $899,347.26.

Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers. The purpose of this contract is to establish a reliable and continuous supply of lenalidomide primarily used to treat multiple myeloma, anemia in myelodysplastic syndromes, and certain types of lymphoma.

From Award Notice posted on Feb 05, 2026

Notice history

Award Notice LATEST Posted Feb 05, 2026

Details

Solicitation number 36C25726N0241

Notice ID 28b8c97608964142bb70fe6da1ef8815

Award number 36F79720D0227

Notice type Award Notice

Product / Service (PSC) 6505

NAICS 325412

Set-aside No Set aside used

Place of performance Big Spring, Texas

Archive date Feb 20, 2026

Award Information

Awardee

Total Awarded

$899,347.26

Award Date

Feb 05, 2026

Award Notices

Lenalidomide Generic Med View Notice

Posted: Feb 05, 2026

Awardees

Company Name	UEI	CAGE Code	Location
EXELAN PHARMACEUTICALS INC	FYZXNHSQTMG8	6GFC4	Boca Raton, FL

Documents

Document 1

Contacts

primary

Tommy Haire

secondary

Matt Lee

Phone

Agency

VETERANS AFFAIRS, DEPARTMENT OF

257-NETWORK CONTRACT OFFICE 17 (36C257)

Place of Performance

Big Spring, Texas 79720
USA

Dates

Posted Feb 05, 2026 6 months ago

Last Updated Aug 06, 2026 2 days ago

Awarded Feb 05, 2026 6 months ago